Advanced Endometrial Cancer Not Yet Recruiting Phase 2 Trials for Lenvatinib (DB09078)

IndicationStatusPhase
DBCOND0050728 (Advanced Endometrial Cancer)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05106127Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus PemTreatment